Ticker Details
Relay Therapeutics, Inc.
IPO Date:	July 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.26B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.66 | 3.76%
Avg Daily Range (30 D):	$0.47 | 2.37%
Avg Daily Range (90 D):	$0.53 | 3.21%

Institutional Daily Volume
Avg Daily Volume:	1.2M
Avg Daily Volume (30 D):	1.66M
Avg Daily Volume (90 D):	2.86M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	86

Institutional Trades
Total Institutional Trades:	3,103
Avg Institutional Trade:	$2.45M
Avg Institutional Trade (30 D):	$4.08M
Avg Institutional Trade (90 D):	$3.45M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.21M
Avg Closing Trade (30 D):	$6.99M
Avg Closing Trade (90 D):	$8.74M
Avg Closing Volume:	227.96K

News

May 22, 2026 @ 9:30 PM Is Relay Therapeutics a Buy After Promising Trial ... Source: James Halley

May 21, 2026 @ 12:21 AM Relay Therapeutics Announces Pricing of Public Off... Source: Not Specified

May 20, 2026 @ 11:01 PM Why Relay Therapeutics Stock Popped on Wednesday Source: Eric Volkman

May 19, 2026 @ 10:00 AM Relay Therapeutics Announces Initial Clinical Data... Source: Na

Apr 27, 2026 @ 10:00 AM Relay Therapeutics Announces Clinical Data for Zov... Source: Relay Therapeutics

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.56	$-.41	$-.41
Diluted EPS	$-1.56	$-.41	$-.41
Revenue	$10.35M	$.35M	$3M
Gross Profit
Net Income / Loss	$-286.04M	$-83.71M	$-73.29M
Operating Income / Loss	$-310.44M	$-90.82M	$-78.59M
Cost of Revenue
Net Cash Flow	$6.33M	$-83.4M	$120.57M
PE Ratio